Arama Sonuçları - Greg Yanik

  • Gösterilen 1 - 8 sonuçlar arası kayıtlar. 8
Sonuçları Daraltın
  1. 1
    FDG PET imaging of childhood sarcomas

    FDG PET imaging of childhood sarcomas Yazar: Rajen Mody, Chuong Bui, Raymond J. Hutchinson, Greg Yanik, Valerie P. Castle, Kirk A. Frey, Barry L. Shulkin

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes

    Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes Yazar: Andrew C. Harris, Carrie L. Kitko, Daniel R. Couriel, Thomas M. Braun, Sung Won Choi, John Magenau, Shin Mineishi, Attaphol Pawarode, Greg Yanik, John E. Levine

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT

    Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT Yazar: Sung Won Choi, Thomas M. Braun, Israel Henig, Erin Gatza, John Magenau, Brian Parkin, Attaphol Pawarode, Mary Mansour Riwes, Greg Yanik, Charles A. Dinarello, Pavan Reddy

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial

    Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial Yazar: Steven G. DuBois, Louis Chesler, Susan Groshen, Randall A. Hawkins, Fariba Goodarzian, Hiroyuki Shimada, Greg Yanik, Michael Tagen, Clinton Stewart, Yaël P. Mossé, John M. Maris, Denice Tsao‐Wei, Araz Marachelian, Judith G. Villablanca, Katherine K. Matthay

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group

    Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group Yazar: Steven G. DuBois, Ethan G. Geier, Vandana Batra, Sook Wah Yee, John Neuhaus, Mark R. Segal, Daniel Martínez, Bruce Pawel, Greg Yanik, Arlene Naranjo, Wendy B. London, Susan G. Kreissman, David L. Baker, Edward F. Attiyeh, Michael D. Hogarty, John M. Maris, Kathleen M. Giacomini, Katherine K. Matthay

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY

    S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY Yazar: Susana Rives, Shannon L. Maude, H. Hiramatsu, André Baruchel, Peter Bader, Henrique Bittencourt, Jochen Buechner, Ted Laetsch, Barbara De Moerloose, Muna Qayed, Heather E. Stefanski, Kara L. Davis, Paul Martin, Eneida R. Nemecek, Christina Peters, Greg Yanik, Adriana Balduzzi, Nicolas Boissel, Seong Lin Khaw, Joerg Krueger, Jun Levine, Sandra Davies, Gary D. Myers, Astrid Yeo, Darragh O’Donovan, Roberto Ramos, M. Pulsipher, S. Grupp

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report

    National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Di... Yazar: Carrie L. Kitko, Joseph Pidala, Hélène Schoemans, Ánita Lawitschka, Mary E.D. Flowers, Edward W. Cowen, Eric R. Tkaczyk, Nosha Farhadfar, Sandeep Jain, Philipp Steven, Zhonghui Luo, Yoko Ogawa, Michael E. Stern, Greg Yanik, Geoff D.E. Cuvelier, Guang-Shing Cheng, Shernan G. Holtan, Kirk R. Schultz, Paul J. Martin, Stephanie J. Lee, Steven Z. Pavletic, Daniel Wolff, Sophie Paczesny, Bruce R. Blazar, Stephanie Sarantopoulos, Gèrard Socié, Hildegard Greinix, Corey Cutler

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

    Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma Yazar: Steven G. DuBois, Yaël P. Mossé, Elizabeth Fox, Rachel A. Kudgus, Joel M. Reid, Renee M. McGovern, Susan Groshen, Rochelle Bagatell, John M. Maris, Clare J. Twist, Kelly C. Goldsmith, Meaghan Granger, Brian Weiss, Julie R. Park, Margaret E. Macy, Susan L. Cohn, Greg Yanik, Lars M. Wagner, Randall A. Hawkins, Jesse Courtier, Hollie Lai, Fariba Goodarzian, Hiroyuki Shimada, Najee Boucher, Scarlett Czarnecki, Chunqiao Luo, Denice Tsao‐Wei, Katherine K. Matthay, Araz Marachelian

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: